Summary
GRx+Biosims 2018 unites the powers of innovation, science and policy to increase patient access to generic and biosimilar medicines. Top-in-their-field speakers and government officials will share best practices and discover new learning tracks in the generic and biosimilars industry. Goodwin's Elaine Blais will be speaking at this conference.
For more information, visit the event website.
Speakers
- /en/people/b/blais-elaine-herrmann
Elaine Herrmann Blais
PartnerCo-Chair, Intellectual Property Litigation